Frank W. Cawood 13D and 13G filings for Barinthus Biotherapeutics plc:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-11 6:43 pm Purchase |
2024-12-31 | 13G | Barinthus Biotherapeutics plc BRNS |
Frank W. Cawood | 3,384,513 8.400% |
1,041,743 (+44.47%) |
Filing |
| 2024-10-15 11:07 am Purchase |
2024-10-07 | 13G | Barinthus Biotherapeutics plc BRNS |
Frank W. Cawood | 2,342,770 5.900% |
2,342,770 (New Position) |
Filing |